Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
WATCH NOWThe FDA's Vaccination Situation, Boehner's Bad Book, & Assessing AfghanistanWatch Here
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Press Release

FreedomWorks Foundation Statement in Response to FDA Commissioner Gottlieb’s Decision to Resign

WASHINGTON, D.C. -- In response to FDA Commissioner Scott Gottlieb’s recent decision to resign, Patrick Hedger, FreedomWorks Foundation Director of Policy, commented:

03/05/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Regulatory_Review_Blog01_2.jpg?itok=azQNhHox
Blog

Regulatory Action Center Review - February 22, 2019

Welcome to FreedomWorks Foundation’s fourth regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.

02/22/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/dairy-breeds-available-in-kenya.jpg?itok=_eCi41YK
Blog

FreedomWorks Foundation Submits Comments on Dairy Alternative Labeling

FreedomWorks Foundation's Regulatory Action Center (RAC) submitted formal written comments to the Food and Drug Administration (FDA) to oppose their proposed rule concerning the labeling of dairy alternatives. This rule would be an infringement on the First Amendment rights of businesses across America by essentially banning the use of phrases such as "almond milk" in commercial use. The full text of our comments can be found below or in the attachment at the bottom of the piece:

01/27/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Regulatory_Review_Blog01_0.jpg?itok=W5g2OGAh
Blog

Regulatory Action Center Review - January 23, 2019

Welcome to FreedomWorks Foundation’s second regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.

01/23/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Press Release

FreedomWorks Statement on FDA’s Decision to Regulate Sale of E-Cigarettes

In response to the FDA’s announcement of its plan to produce a regulation to ban the sale of flavored e-cigarettes in most stores, Patrick Hedger, FreedomWorks Director of Policy, commented:

11/09/2018
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Screen%20Shot%202018-03-21%20at%203.24.07%20PM.png?itok=A76DOR7K
Blog

House Reconsiders Democrats’ Move to Deny Hope to Terminally Ill Patients

Sarah Anderson co-authored this post.

03/21/2018
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/CREATES%20Money.jpg?itok=chlwQIQy
Blog

CREATES Act Opponents are Direly Wrong

Once in a long while, Congress finds a bipartisan fix for dire issues like prescription drug prices. The CREATES Act is such a solution that would remedy price-hiking loopholes abused by big pharmaceutical companies.

03/07/2018
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/dope.jpg?itok=JuTXft2P
Blog

A Free Market Approach to Prescription Drugs

In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.

02/06/2018
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/food%20counter.jpg?itok=J3x1Wu3w
Blog

Jail Time for Too Much Meat on a Sandwich?

Time and time again, the federal government has encroached into a sector of the economy and imposed a one-size-fits-all regulation that stifles competition, hurts small businesses, and creates troubling criminal penalties for lack of compliance. This is epitomized in federal involvement in menu labeling -- regulations and requirements for private businesses to disclose caloric information on physical menus.

12/11/2017
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/McLinn%20Pence%20Right%20to%20Try.jpg?itok=fhzruHu9
Op-ed Placement

Lives Hang in the Balance While the FDA Bureaucracy Churns

The McLinn family of Indianapolis is still fighting for their seven-year-old son, Jordan, who was diagnosed at the age of 3 with Duchenne muscular dystrophy. This is an aggressive disease that results in muscle weakness and loss first attacking the extremities, eventually moving to the heart and other internal organs. There is no known cure, yet, but there are treatments that can help manage symptoms and slow progression of the disease.

08/10/2017

Pages